Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

Summary

The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).

Timeline

Start

2019-08-15

Primary completion

2025-02-02

Completion

2028-04-01

Publications

• Liu AP, Cheuk DK. Disease-modifying treatments for primary autoimmune haemolytic anaemia. Cochrane Database Syst Rev. 2021 Mar 26;3(3):CD012493. doi: 10.1002/14651858.CD012493.pub2.

Drugs

Indications